Christian Heidbreder
Chief Scientific OfficerDr. Christian Heidbreder serves as the Chief Scientific Officer at Supernus, Inc. (formerly known as Indivior Pharmaceuticals, Inc.) (formerly known as Indivior PLC) since December 2014 and also served as it's Head of Research and Development. He served as Global R&D Director at Reckitt Benckiser Pharmaceuticals Inc. He served at GlaxoSmithKline, Center of Excellence for Drug Discovery in Psychiatry. Dr. Heidbreder holds leadership experience in the neurosciences spanning the academic, governmental and industrial sectors across Europe and the US. During his career, he has published over 350 peer-reviewed scientific publications, reviews, book chapters and published conference proceedings. He began his career as a researcher at the National Institute on Drug Abuse in Baltimore, at Princeton University and at the Swiss Federal Institute of Technology in Zürich. Dr. Heidbreder subsequently served positions of increasing responsibility at SmithKline-Beecham's Neuroscience Department in Harlow, GSK's R&D Centre of Excellence for Drug Discovery in Psychiatry in Verona and Altria Client Services' Health Sciences Department in Richmond, Virginia. He served as Global R&D Director at RBP in 2009 with a remit to lead global strategies (including Strategic Portfolio Management, Preclinical and Clinical Development, Health Economics Research, Chemistry, Manufacturing & Controls and Regulatory Affairs) to drive the development of new pharmacotherapies in the area of addiction and related co-morbidities. He is also an Affiliate Professor in the Department of Pharmacology & Toxicology of the Virginia Commonwealth University School of Medicine. He is the Member of the Helping to End Addiction Long-term (HEAL) Multi-Disciplinary Working Group. He is National Institute on Drug Abuse at : Intramural Research Program. He is the Member of the National Advisory Council on Drug Abuse. He holds BA, MA and PhD degrees from the University of Louvain and a Certificate in Strategic Innovation from the Wharton Business School.
Positions
- Company NameSupernus, Inc.Stock CodeSUPNPositionChief Scientific OfficerColleagues
- SAStuart Anthony KingsleyIndependent Non-Executive Chair
- JAJack A. KhattarPresident, CEO & Director
- TCTimothy C. DecSenior VP & CFO
- JTJason ThompsonVice President of Investor Relations
- KLKevin L. EspinozaChief Integrity & Compliance Officer
- JTJuliet ThompsonLead Independent Director
- MPMark P. StejbachIndependent Non-Executive Director
- KHKeith HumphreysIndependent Non-Executive Director
